Beacon Topco, Inc. SEC filings CLYD
Beacon Topco, Inc. has 18 filings in SEC EDGAR's recent list, going back to Nov 7, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Nov 5, 2026 | Oct 31, 2026 |
| SC TO-I/A | Filing | Oct 21, 2026 | — |
| SC TO-I/A | Filing | Oct 13, 2026 | — |
| SC TO-I/A | Filing | Sep 29, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Sep 24, 2026 | Sep 22, 2026 |
| SC TO-I/A | Filing | Sep 24, 2026 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 17, 2026 | Sep 15, 2026 |
| SC TO-I | Filing | Sep 15, 2026 | — |
| 10-Q | Quarterly report | Jul 14, 2026 | Jun 30, 2026 |
| SP 15D2 | Filing | Jul 2, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Jun 5, 2026 | Mar 31, 2026 |
| 424B3 | Prospectus | Apr 23, 2026 | — |
| EFFECT | Filing | Apr 22, 2026 | — |
| S-4/A | Filing | Apr 13, 2026 | — |
| S-4/A | Filing | Mar 31, 2026 | — |
| S-4/A | Filing | Mar 13, 2026 | — |
| S-4/A | Filing | Jan 27, 2026 | — |
| S-4 | Registration for a merger or exchange | Nov 7, 2025 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLYD
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Germantown, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2094256
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.